These Biotech Stocks Could Get “Let Out Of The Cage” This Year
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…
Small-Cap Biotechs
This New Fund Offers Targeted Exposure To Junior Biotech Disruptors
There’s a new ETF on the scene with a focus on small-cap biotech companies, offering investors exposure to junior disruptors in the biotech space. For…
Attractive Prices And Plenty Of Upside Make These 2 “Cutting Edge” Cancer Stocks Potential Buys
In the cancer treatment space, today’s article highlights two small-cap biotech names to consider this month based on their attractive prices and potential to “take…
Large And Small, These Biotech Stocks Could Be Big Winners
One large-cap biotech and two small-cap biotechs – one which “has been content with staying out of the limelight” and a second, higher-risk play –…
Why This Biotech’s Mixed Clinical Results Shouldn’t Discourage Investors With A High Risk Tolerance
The small-cap biotech highlighted in today’s article has had mixed clinical results when it comes to one of its novel cancer immunotherapy candidates. The author,…